Sweetgreen is trading 5.6% higher at $8.14, with its recovery appearing tied to continued relief after the CDC declared the cyclospora outbreak over, despite Consumer Discretionary falling 1.59% during the September 24, 2026 session. - No fresh September 24 company announcement was identified. - Recent bullish analyst actions include KeyBanc’s Overweight upgrade and a $9 target.